Kourane Sissoko Selected Research

COVID-19

1/2022

Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West Africa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kourane Sissoko Research Topics

Disease

5	Malaria 11/2023 - 01/2017
2	Infections 01/2022 - 01/2017
1	COVID-19 01/2022
1	Hepatitis C 01/2018
1	Hepatitis B 01/2018
1	Myalgia 01/2017
1	Fatigue 01/2017
1	Fever (Fevers) 01/2017
1	Headache (Headaches) 01/2017
1	Falciparum Malaria (Plasmodium falciparum Malaria) 04/2009

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 11/2023 - 01/2017
1	Aluminum Hydroxide (Algeldrate)FDA Link 11/2023
1	Antimalarials (Antimalarial Agents)IBA 01/2022
1	A-factor (Streptomyces)IBA 01/2022
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	AntibodiesIBA 01/2018
1	Malaria VaccinesIBA 01/2018
1	Pyrimethamine (Daraprim)FDA Link 04/2009
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 04/2009
1	ArtesunateIBA 04/2009